13F

Stock

UroGen Pharma Ltd.

URGN · held by 10 managers

Reported value

$66.2M

Holders

10

+1 new · −0 exited

Holders’ est. mark

$4.05M

Price effect on 4 books still in the name

Largest holder

$50.4M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY2.53M$50.4MHeld
Boxer Capital Management, LLC575K$11.5M$3.59MAdded$3.59M
BANK OF AMERICA CORP /DE/108.5K$2.16MHeld
BARCLAYS PLC55.6K$1.11M$347.6KAdded$148.5K
Persistent Asset Partners Ltd20.7K$413.5KHeld
Cresset Asset Management, LLC16.7K$333.5K$104.5KAdded$104.5K
FARALLON CAPITAL MANAGEMENT LLC11K$219.4KNew
Allworth Financial LP149$2.97KHeld
Essential Partners LLC115$2.29K$674Added$814
IFP Advisors, Inc34$678Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.